Saverna Therapeutics is a cutting-edge brand that is revolutionizing the field of pharmaceutical discovery and development. Founded in 2017, our mission is to transform the way drugs are created by focusing on safe and orally active small molecules that target non-coding RNA-biology. At Saverna Therapeutics, we utilize a platform powered by the latest Artificial Intelligence tools and Nuclear Magnetic Resonance technology.

This allows us to significantly reduce both the time and costs associated with drug discovery. Our team of experts is dedicated to discovering highly active, selective, and cell-permeable low molecular weight molecules that specifically target RNA biology in order to treat diseases with unmet medical needs. To date, our groundbreaking research has been funded through a combination of self-funding and prestigious grant awards from Switzerland and Europe, including Innosuisse and Eurostars programs.

Stay up-to-date with our latest news and developments, and join us at industry conferences such as the RESI ASIA, Drug Discovery Strategic Summit, and Targeting RNA congress. You can find us at our headquarters in Allschwill, Switzerland. Contact us today to learn more about our innovative approach to drug discovery